NCT00087477View on ClinicalTrials.gov

A Pilot Study of Pivanex in Patients With Malignant Melanoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

August 31, 2004

Conditions
Malignant Melanoma
Interventions
DRUG

Pivanex

Trial Locations (1)

33140

Mt. Sinai Comprehensive Cancer Center, Miami Beach

Sponsors
All Listed Sponsors
lead

Titan Pharmaceuticals

INDUSTRY

NCT00087477 - A Pilot Study of Pivanex in Patients With Malignant Melanoma | Biotech Hunter | Biotech Hunter